Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Peringkat dalam Saham #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Harga Saham
$0.069
Terakhir disinkronkan: 2024-07-22
Kapitalisasi Pasar
$2.06M
Perubahan (1 hari)
-1.43%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan DermTech, Inc. (DMTK)

Kategori

Laba untuk DermTech, Inc. (DMTK)
Laba pada Mar 2024 TTM: $-89.63M
Menurut laporan keuangan terbaru dari DermTech, Inc., laba saat ini perusahaan adalah $-89.63M. Pada tahun 2022, perusahaan memperoleh laba sebesar $-116.68M, penurunan dibandingkan dengan laba tahun 2021 sebesar $-78.34M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk DermTech, Inc. dari 2012 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $-89.63M -11.16%
2023 $-100.89M -13.54%
2022 $-116.68M 48.95%
2021 $-78.34M 114.75%
2020 $-36.48M 85.27%
2019 $-19.69M -2,184.69%
2018 $944.46K -1,574,196.67%
2017 $-60.00 -100.00%
2013 $-5.18M 132.41%
2012 $-2.23M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$7.61B -8,589.53%
US
$4.76B -5,413.07%
US
- -
CN
$-252.70M 181.94%
US
$1.42B -1,689.26%
US